TL;DR
A review in Mammalian Genome examines whether taurine metabolism could be a target for protecting the nervous system in age-related disease. Findings from animal, laboratory and limited human research are suggestive, but they do not show that taurine supplements prevent dementia or slow brain aging in people.
A review published in Mammalian Genome examines whether changes in taurine metabolism could help protect the nervous system against age-related neurodegenerative diseases. The review’s authors describe promising findings from animal and laboratory studies, but do not establish that taurine supplements prevent dementia or preserve cognition in older adults.
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
The review was conducted by scientists from Karolinska Institutet and St. Erik Eye Hospital in Sweden, in collaboration with researchers at the University of Pisa, King’s College London and the Center for Eye Research Australia. In the article, the authors consider taurine’s functions in the nervous system, how the body obtains and distributes it, and research linking taurine to conditions including Alzheimer’s and Parkinson’s disease.
As the review describes, taurine is an amino sulfonic acid found naturally in mammalian tissues and especially abundant in the brain and nervous system. It is not used to build proteins. The authors discuss possible protective roles, including regulating water balance in cells, stabilizing calcium levels, supporting mitochondrial processes and influencing signaling between neurons. They suggest these mechanisms could help limit cellular stress and excessive neuronal activity, while emphasizing that proposed mechanisms do not by themselves prove a clinical benefit.
The authors cite experiments in which taurine treatment improved learning or memory measures in aged mice and reduced signs of damage in models of Alzheimer’s disease. They also summarize laboratory work, including experiments with patient-derived cerebral organoids, that reported reductions in amyloid-beta deposits and pathological tau accumulation after treatment. The review characterizes these as preclinical findings: they do not show that taurine has the same effects in people or that supplements can prevent or treat a neurodegenerative disease.
From Lab Findings to Human Benefit
The review brings together several lines of research into a substance that occurs naturally in the body and in foods. Its discussion of taurine’s apparent roles in cellular stress, neural signaling and mitochondrial function gives researchers reasons to investigate whether taurine metabolism changes with age and whether those changes are relevant to brain disease.
But the gap between an effect in mice or cells and a useful intervention for people is substantial. The review does not establish an effective dose, long-term safety for supplementation, or whether taking taurine changes the risk or course of dementia. For readers, the main takeaway is that taurine is a research lead, not a proven brain-aging treatment. The review should not be read as a recommendation to start supplements or replace medical care.
Products Worth Considering

BowFlex Results Series SelectTech Adjustable Dumbbells (Pair)

Oura Ring 5 Smart Ring, Silver, Size 8

Levoit Core 600S-P Smart Air Purifier for Large Rooms up to 2933 ft²
As an affiliate, we earn on qualifying purchases.
How the Body Gets Taurine
The review explains that people obtain taurine from foods including meat, fish, poultry and dairy, while the body also makes some taurine from sulfur-containing amino acids. The authors note that humans have a relatively limited capacity to synthesize it. Taurine from food is absorbed through the digestive tract, distributed through the circulation and taken up by tissues with the help of transporters. The review identifies SLC6A6 as a transporter that helps move taurine across the blood-brain barrier.
According to the review, the brain has limited capacity to produce taurine and relies largely on uptake to maintain its levels. The authors describe the kidneys as helping regulate circulating amounts by excreting more taurine in urine when levels rise after dietary intake. They also cite reports of lower taurine levels in some aging tissues and pathological conditions, including inflammation and trauma. The review notes that such associations do not show whether low taurine contributes to disease, results from it, or reflects other factors.
The authors discuss a small postmortem study that found lower taurine in the temporal cortex of people with Alzheimer’s disease than in healthy controls. They also cite reports of lower plasma taurine in people with Parkinson’s disease. These observations are limited and cannot establish taurine deficiency as a cause of either condition. The review provides no evidence that measuring taurine levels can diagnose these diseases or guide treatment.
The Human Evidence Gap
The central uncertainty identified by the review is whether effects reported in laboratory and animal research translate into meaningful outcomes for people. The authors do not report a large clinical trial showing that taurine supplementation prevents dementia, slows cognitive decline or treats Alzheimer’s or Parkinson’s disease. The review also does not establish which people, if any, might benefit, at what dose, or for how long.
The review describes lower taurine levels observed in disease studies as associations, not proof of cause and effect. It remains unclear whether those levels precede illness, arise as a consequence of illness, or are influenced by diet, age or other health factors. The authors’ mechanistic explanations and preclinical results support further study, but do not resolve these questions.
Evidence Needed Before Treatment Claims
The review points to the need for research that can test taurine’s effects in people, rather than infer them from cells and animals. The authors note that well-designed clinical studies would need to examine cognitive outcomes, appropriate dosing and safety over time, while distinguishing supplementation from taurine obtained through food. The review does not identify a specific upcoming trial or give a timeline for such work.
Until stronger human evidence is available, the review supports continued investigation of taurine metabolism as a possible research target, not a claim that supplements protect the aging brain. Anyone considering a supplement for a health condition should discuss that decision with a qualified health professional.
Key Questions
Does taurine prevent dementia?
The review does not show that taurine prevents dementia. Its authors describe animal and laboratory findings that warrant further study, but human preventive effects have not been established in the review.
What did the review find about taurine and Alzheimer’s disease?
The review’s authors summarize a small postmortem study reporting lower taurine in the temporal cortex of people with Alzheimer’s, along with experiments in mice and cerebral organoids that reported potentially protective effects. These findings do not prove taurine prevents or treats Alzheimer’s in people.
Which foods contain taurine?
The review lists meat, fish, poultry and dairy as taurine-containing foods. It also names seafood such as scallops, mussels and clams among foods with relatively high reported taurine concentrations, while actual amounts vary by species and preparation.
Should older adults take taurine supplements for brain health?
The review does not establish a supplement dose or show that supplementation preserves cognition in older adults. It is not a treatment recommendation; people considering supplements should consult a qualified health professional.
Source: news-medical.net
